Erlotero 150 mg Tablet
  1. Home
  2. Pharma Products
  3. Hetero Healthcare Ltd
  4. Erlotero 150 mg Tablet

Erlotero 150 mg Tablet

Erlotero 150 mg Tablet contains erlotinib 150 mg and is an oral targeted anticancer medicine. It is used for certain cases of non-small cell lung cancer and advanced pancreatic cancer. The tablet is a prescription medicine and should be taken under the supervision of an oncologist.

BUY NOW

Category

Erlotinib is a tyrosine kinase inhibitor that blocks epidermal growth factor receptor (EGFR) signaling, which can help slow the growth and spread of certain cancer cells. It may be used alone for specific non-small cell lung cancers or with other medicines for advanced pancreatic cancer according to the treatment plan. Erlotero should generally be taken on an empty stomach, at least 1 hour before or 2 hours after food. Regular medical monitoring may be required because treatment can cause rash, diarrhea, fatigue, liver-related effects, and other adverse reactions.

Technical Specification

Specification Details
Active Ingredient Erlotinib
Strength 150 mg
Dosage Form Tablet
Pack Size 30 tablets
Route of Administration Oral
Manufacturer/Marketer Hetero Drugs Ltd.

Product Also Known As

Erlotero 150mg Tablet, Erlotero 150 mg Tablet, Erlotero 150 Tablet, Erlotinib 150mg Tablet, Erlotinib 150 mg Tablet, Erlotinib Hydrochloride 150mg Tablet, Erlotinib Oral Tablet